Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SEN-177 is a glutaminyl cyclase inhibitor (IC50 = 53 nM).1 It reduces polyglutamine aggregation in HeLa cells expressing EGFP-HTT-Q74, an in vitro model of Huntington’s disease when used at concentrations of 12.5 and 25 µM.2 SEN-177 (50 µM) reduces polyglutamine aggregation in primary mouse neurons expressing EGFP-Q80.
WARNING This product is not for human or veterinary use.
1. 2-
2. siRNA screen identifies QPCT as a druggable target for Huntington’s disease. Nat. Chem. Biol. 11(5), 347-354 (2015).